UBS Group »

Day One Biopharmaceuticals I shares owned by UBS Group

Quarter-by-quarter ownership of Day One Biopharmaceuticals I (DAWN) shares owned by UBS Group from 13F filings

Historical chart of UBS Group investment in Day One Biopharmaceuticals I

Tip: Access up to 7 years of quarterly data

All positions including Day One Biopharmaceuticals I held by UBS Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Day One Biopharmaceuticals I by UBS Group

Quarter filed Position value Share count Share price at filing
2025-09-30 $1.5M 210k 7.05
2025-06-30 $582k 90k 6.50
2025-03-31 $985k 124k 7.93
2024-12-31 $814k 64k 12.67
2024-09-30 $1.6M 115k 13.93
2024-06-30 $966k 70k 13.78
2024-03-31 $2.7M 164k 16.52
2023-12-31 $1.8M 127k 14.60
2023-09-30 $293k 24k 12.27
2023-06-30 $150k 13k 11.93
2023-03-31 $934k 70k 13.37
2022-12-31 $2.8M 130k 21.52
2022-09-30 $366k 22k 16.95
2022-06-30 $69k 3.9k 17.92
2021-12-31 $104k 6.1k 16.97
2021-09-30 $1.0k 59 16.95